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ABSTRACT Hepatitis E virus genotype 3 (HEV-3) is the causal pathogen of chronic
hepatitis E. We report here the full-length genome sequence of an HEV-3 strain, iso-
lated from a kidney transplant recipient in Switzerland (SW/16-0282). This HEV-3
strain showed less than 88% homology compared to known strains, suggesting a
new HEV-3 strain.
Hepatitis E virus (HEV) is a single-stranded RNA virus and a common cause of acutehepatitis (1, 2). Four main HEV genotypes, as well as the recently reported HEV
genotype 7, infecting humans have been described. HEV genotypes 1 and 2 have been
linked to waterborne outbreaks in developing countries that exclusively infect humans.
In contrast, HEV genotypes 3, 4, and 7 are predominant in industrialized countries, while
zoonotic transmission from animal reservoirs to human has been suggested (3, 4). It is
well established that prolonged HEV viremia and chronic hepatitis E with HEV genotype
3 (HEV-3) can occur in immunocompromised patients (5, 6). Recent studies revealed an
HEV-seroprevalence among blood donors (4.9%) and chronic infections in patients with
HIV (2.6%) in Switzerland. However, HEV seroprevalence in Switzerland is considerably
lower than in other European countries, which may be explained by the strict regula-
tion of animal and meat imports (7–9). Here, we report the full-length genome
sequence of an HEV-3 strain (SW/16-0282), isolated from a kidney transplant recipient
with chronic hepatitis E in Switzerland.
The virus was isolated from a 58-year-old male kidney transplant recipient from
Lachen, Switzerland. The patient presented clinically with hepatitis symptoms and
moderate elevated liver enzymes in June 2016 while being treated with immunosup-
pressive drugs. The first test for HEV IgM/ IgG was negative and hepatitis was consid-
ered because of drug toxicity. No recovery of hepatitis was seen despite changing
drugs. In August 2016, a diagnosis of hepatitis E relied on a further increase of liver
enzyme levels and detection of anti-HEV IgM/IgG and HEV RNA in serum (3.1  10E5
IU/mL) and feces (2.7  10E7 IU/mL stool suspension). The HEV IgG/IgM immunoas-
say (recomLine, Mikrogen, Germany) showed a clear response to the C-terminal part of
the capsid antigen (O2C; genotype 3). However, there was no evidence for a specific
HEV-3 strain. Nutritional regimens limited the patient’s meat consumption to beef and
fish (no venison and swine).
Viral RNA extraction from patient serum and feces was performed using the High
Pure Viral nucleic acid kit (Roche Diagnostics, Germany) according to the manufactur-
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er’s instructions. After cDNA synthesis using Transcriptor first-strand cDNA synthesis
(Roche Diagnostics, Germany), the complete viral genome was amplified using KAPA
HiFi HotStart ReadyMix PCR (Kapa Biosystems, USA). The 5= and 3= sequences were
determined using 5= and 3= rapid amplification of cDNA ends (Roche Diagnostics,
Germany). HEV amplicons were sequenced with the BigDye Terminator version 3.1
cycle sequencing kit (Applied Biosystems, USA) in both directions. Whole-genome
sequence and phylogenetic analyses were done using Geneious version 10.0.5 and
MEGA7 software (10).
The complete genome of SW/16-0282 is 7,222 nucleotides in length, excluding the
poly(A)-tail, with a GC content of 56% harboring the expected HEV open reading
frames (ORFs) with 1,703 (ORF1), 660 (ORF2), and 122 (ORF3) amino acids, respectively.
Phylogenetic reconstructions based on the whole-genome sequences demonstrated
that SW/16-0282 belongs to HEV-3. SW/16-0282 shared the highest homology with the
HEV subgenotype 3h TR19 strain (87.8%; JQ013794). Because of the poor homology to
any HEV-3 subgenotype, it must be verified by comprehensive genetic analyses of HEV
strains from human and animal reservoirs whether the SW/16-0282 strain represents a
new HEV subgenotype 3l.
Accession number(s). The complete genome sequence of SW/16-0282 has been
deposited in GenBank under the accession number KY780957.
ACKNOWLEDGMENTS
We are grateful for the excellent technical assistance of Marcel Schulze. B.W. is
supported by the China Scholarship Council (CSC), Beijing, China. D.H. is supported by
a scholarship from the Claussen-Simon-Stiftung (Claussen-Simon Foundation) “Disser-
tation Plus” program, Germany. The content is the responsibility only of the authors and
does not represent the views of CSC or Claussen-Simon-Stiftung.
REFERENCES
1. Wedemeyer H, Pischke S, Manns MP. 2012. Pathogenesis and treatment
of hepatitis E virus infection. Gastroenterology 142:1388 –1397.e1.
https://doi.org/10.1053/j.gastro.2012.02.014.
2. van Tong H, Hoan NX, Wang B, Wedemeyer H, Bock CT, Velavan TP. 2016.
Hepatitis E virus mutations: functional and clinical relevance. EBioMedi-
cine 11:31– 42. https://doi.org/10.1016/j.ebiom.2016.07.039.
3. Meng XJ. 2010. Hepatitis E virus: animal reservoirs and zoonotic risk. Vet
Microbiol 140:256 –265. https://doi.org/10.1016/j.vetmic.2009.03.017.
4. Lee G, Tan B, Chi-Yuan Teo E, Lim S, Dan Y, Wee A, Kim Aw PP, Zhu Y,
Hibberd ML, Tan C, Purdy MA, Teo C. 2016. Chronic infection with
camelid hepatitis E virus in a liver transplant recipient who regularly
consumes camel meat and milk. Gastroenterology 150:355–357. https://
doi.org/10.1053/j.gastro.2015.10.048.
5. Behrendt P, Steinmann E, Manns MP, Wedemeyer H. 2014. The impact of
hepatitis E in the liver transplant setting. J Hepatol 61:1418 –1429.
https://doi.org/10.1016/j.jhep.2014.08.047.
6. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, Cointault
O, Esposito L, Abravanel F, Danjoux M, Durand D, Vinel JP, Izopet J,
Rostaing L. 2008. Hepatitis E virus and chronic hepatitis in organ-
transplant recipients. N Engl J Med 358:811– 817. https://doi.org/10
.1056/NEJMoa0706992.
7. Kaufmann A, Kenfak-Foguena A, André C, Canellini G, Bürgisser P, Mo-
radpour D, Darling KE, Cavassini M. 2011. Hepatitis E virus seropreva-
lence among blood donors in southwest Switzerland. PLoS One
6:e21150. https://doi.org/10.1371/journal.pone.0021150.
8. Kenfak-Foguena A, Schöni-Affolter F, Bürgisser P, Witteck A, Darling KE,
Kovari H, Kaiser L, Evison JM, Elzi L, Gurter-De La Fuente V, Jost J,
Moradpour D, Abravanel F, Izpopet J, Cavassini M, Swiss HIV Cohort
Study. 2011. Hepatitis E virus seroprevalence and chronic infections in
patients with HIV, Switzerland. Emerg Infect Dis 17:1074 –1078. https://
doi.org/10.3201/eid/1706.101067.
9. Pavio N, Mansuy JM. 2010. Hepatitis E in high-income countries. Curr
Opin Infect Dis 23:521–527. https://doi.org/10.1097/QCO.0b01
3e32833de683.
10. Wang B, Yang XL, Li W, Zhu Y, Ge XY, Zhang LB, Zhang YZ, Bock CT, Shi
ZL. 2017. Detection and genome characterization of four novel bat
hepadnaviruses and a hepevirus in China. Virol J 14:40. https://doi.org/
10.1186/s12985-017-0706-8.
Wang et al.
Volume 5 Issue 20 e00345-17 genomea.asm.org 2
